2015 ANNUAL RESULTS

2015 ANNUAL RESULTS

AGGREGATE SALES & BUSINESS EPS

2015 SALES 2015 BUSINESS EPS

5.64

2014 SALES

5.20 2014 BUSINESS EPS

37,057m 33,770m

2015 AGGREGATE SALES

11,633m

ESTABLISHED Rx PRODUCTS

7,580m

DIABETES

4,743m

VACCINES

3,664m

GENZYME

3,492m

CONSUMER HEALTHCARE

2,515m

ANIMAL HEALTH

1,917m

GENERICS

1,504m

ONCOLOGY

2015 AGGREGATE SALES BY GEOGRAPHY

UNITED STATES

13,406m

ASIA

3,732m

LATIN AMERICA

3,305m

WESTERN EUROPE

8,026m

EASTERN EUROPE, RUSSIA & TURKEY

2,429m

REST OF THE WORLD*

3,611m

AFRICA & MIDDLE EAST

2,319m

* Note that image is illustrative only. Rest of the world sales include Japan, South Korea, Canada, Australia and New Zealand.

For full financial data and non-GAAP reconciliations, please refer to Sanofi's 2015 Annual Results and Presentation issued February 9, 2016, available at

For more information, visit sanofi.us

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download